Yuqiang Wang Selected Research

N-methyl-d-aspartate receptor antagonist MN-08

1/2019

The novel N-methyl-d-aspartate receptor antagonist MN-08 ameliorates lipopolysaccharide-induced acute lung injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuqiang Wang Research Topics

Disease

18	Parkinson Disease (Parkinson's Disease) 04/2024 - 07/2006
15	Ischemic Stroke 01/2023 - 10/2008
12	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 07/2006
12	Neoplasms (Cancer) 01/2022 - 01/2001
11	Stroke (Strokes) 03/2024 - 10/2008
7	Inflammation (Inflammations) 12/2022 - 06/2015
7	Myocardial Ischemia (Ischemic Heart Diseases) 02/2021 - 09/2013
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 07/2015
4	Acute Lung Injury 12/2022 - 06/2014
4	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2016
4	Leukemia 12/2015 - 01/2001
3	Fibrosis (Cirrhosis) 03/2024 - 01/2021
3	Hypoxia (Hypoxemia) 01/2022 - 01/2017
3	Hypertension (High Blood Pressure) 01/2022 - 01/2012
3	Colitis 01/2020 - 01/2016
3	Pain (Aches) 02/2019 - 09/2014
3	Infarction (Infarctions) 01/2018 - 11/2016
3	Myocardial Infarction 01/2018 - 06/2015
3	Cerebral Infarction 01/2018 - 10/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 04/2017 - 05/2016
3	Leukemia L1210 01/2012 - 10/2005
2	Dementia (Dementias) 04/2024 - 01/2020
2	Brain Diseases (Brain Disorder) 03/2024 - 01/2018
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2024 - 07/2020
2	Lung Injury 12/2022 - 01/2022
2	Anemia 01/2022 - 09/2021
2	Reperfusion Injury 02/2021 - 09/2017
2	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 12/2019
2	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2019 - 11/2016
2	Neuralgia (Stump Neuralgia) 02/2019 - 01/2019
2	Spinal Cord Injuries (Spinal Cord Injury) 02/2019 - 01/2019
2	Cardiotoxicity 01/2019 - 01/2016
2	Body Weight (Weight, Body) 01/2019 - 10/2010
2	Intracranial Vasospasm 01/2019 - 01/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2017 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2017 - 08/2015
2	Wounds and Injuries (Trauma) 05/2017 - 01/2017
2	Neuroblastoma 01/2017 - 10/2016
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2016 - 10/2015
1	Hemorrhage 03/2023
1	Thrombosis (Thrombus) 03/2023
1	Septic Shock (Toxic Shock Syndrome) 12/2022
1	Sepsis (Septicemia) 12/2022

Drug/Important Bio-Agent (IBA)

17	Neuroprotective AgentsIBA 01/2023 - 10/2008
16	tetramethylpyrazineIBA 03/2024 - 06/2011
14	tetramethylpyrazine nitroneIBA 03/2024 - 08/2012
11	Free RadicalsIBA 01/2023 - 10/2008
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2015
8	Memantine (Namenda)FDA Link 04/2024 - 07/2006
8	Thymidine Monophosphate (TMP)IBA 03/2024 - 10/2008
8	Therapeutic UsesIBA 01/2023 - 08/2012
7	andrographolideIBA 01/2022 - 07/2009
7	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 07/2006
7	3,4-dihydroxyphenyllactic acidIBA 01/2019 - 06/2015
6	NitratesIBA 04/2024 - 01/2017
6	Ephrin-A5 (AL-1)IBA 01/2022 - 07/2014
6	DT-010IBA 02/2021 - 01/2016
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2006
4	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 06/2015
4	N-Methylaspartate (NMDA)IBA 12/2022 - 01/2019
4	CalciumIBA 07/2020 - 01/2014
4	EnzymesIBA 12/2017 - 01/2001
3	SynucleinsIBA 04/2024 - 01/2020
3	LipopolysaccharidesIBA 12/2022 - 06/2014
3	Glutamic Acid (Glutamate)FDA Link 07/2020 - 01/2018
3	Monoamine Oxidase (MAO)IBA 11/2017 - 01/2017
3	ProdrugsIBA 07/2008 - 01/2001
3	CC 1065IBA 04/2003 - 01/2001
2	Amyloid beta-PeptidesIBA 01/2023 - 01/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2022 - 01/2016
2	InflammasomesIBA 12/2022 - 01/2022
2	CytokinesIBA 01/2022 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2002
2	VimentinIBA 01/2022 - 11/2016
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 11/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 10/2019
2	ProteomeIBA 06/2019 - 02/2015
2	dehydrocorybulbineIBA 02/2019 - 01/2019
2	Purinergic P2X4 ReceptorsIBA 02/2019 - 01/2019
2	Trinitrobenzenesulfonic AcidIBA 01/2019 - 01/2016
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019 - 10/2016
2	MEF2 Transcription FactorsIBA 11/2018 - 11/2017
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2017 - 07/2014
2	Cholinesterases (Cholinesterase)IBA 04/2017 - 01/2017
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 07/2014
2	chrysinIBA 07/2016 - 07/2015
2	AntioxidantsIBA 01/2016 - 07/2015
2	Peptides (Polypeptides)IBA 10/2015 - 02/2015
2	Amlodipine (Norvasc)FDA LinkGeneric 09/2014 - 09/2013
2	homocamptothecinIBA 01/2012 - 10/2005
1	Hematoxylin (Haematoxylon)IBA 03/2024
1	Galactose (Galactopyranose)FDA LinkGeneric 03/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2024
1	Adenosine Triphosphate (ATP)IBA 03/2024
1	Matrix Metalloproteinases (MMPs)IBA 03/2024
1	Heparin (Liquaemin)FDA LinkGeneric 03/2023
1	bivalirudin (Angiomax)FDA Link 03/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2022
1	Valsartan (Vals)FDA Link 01/2022

Therapy/Procedure

15	Therapeutics 02/2021 - 01/2001